title: Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies.
authors: Mónica
authors: M
authors: Martín-Salces
authors: Víctor
authors: V
authors: Jiménez-Yuste
authors: María Teresa
authors: MT
authors: Álvarez-Román
authors: Isabel
authors: I
authors: Rivas-Pollmar
authors: Ana
authors: A
authors: Rodríguez de la Rúa
mesh_terms: D000328:Adult; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D001803:Blood Transfusion; D002585:Cesarean Section; D005169:Factor VIII / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007518:Isoantibodies / Q000097:blood; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000276:immunology / Q000628:therapy*; D014148:Tranexamic Acid / Q000008:administration & dosage; D014592:Uterine Hemorrhage / Q000209:etiology / Q000628:therapy; D056729:von Willebrand Disease, Type 3 / Q000097:blood / Q000150:complications* / Q000276:immunology / Q000628:therapy*; D014841:von Willebrand Factor / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D000933:Antifibrinolytic Agents; D007518:Isoantibodies; D014841:von Willebrand Factor; D014148:Tranexamic Acid; C078147:F8 protein, human; D005169:Factor VIII